UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug (Q61628446)
Jump to navigation
Jump to search
scientific article published on 6 August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug |
scientific article published on 6 August 2008 |
Statements
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug (English)
0 references
Adrian Kielhorn
Alexander Diamantopoulos
6 August 2008
0 references